Hiring of Previous Indian Investment Banker by LeapFrog to Bolster Healthcare Investment Division
LeapFrog Investments, a private equity firm backed by Temasek, has bolstered its healthcare strategy with the addition of a former executive from an Indian mid-market investment bank. The new hire will play a pivotal role in expanding LeapFrog's footprint and impact in the healthcare sector within growth markets.
In a move aimed at strengthening its healthcare focus in high-growth emerging markets, LeapFrog Investments, which invests in healthcare and financial services targeted at emerging consumers in regions including South Asia, Southeast Asia, and Africa, has brought on board this seasoned professional [1]. Although the identity of the executive remains undisclosed, it is clear that their role will involve leveraging their background to drive the firm's healthcare strategy further in these regions.
This move aligns with LeapFrog’s broader mission of backing impactful tech-enabled businesses delivering essential healthcare services across these regions [1]. The firm has previously backed Indian companies such as Redcliffe Labs and Healthify.
Meanwhile, in a separate development, Canada's OTPP is exiting its stake in Sahyadri Hospitals. The healthcare provider has been acquired by Manipal, a Temasek-controlled company. The financial details of the deal were not disclosed.
Temasek, the Singaporean investment company, has also reported a record high portfolio value. Despite the potential risks from the US, the company has stated that these may have peaked [4].
LeapFrog Investments, on the other hand, has reported strong revenue growth and a narrowing of losses in FY25, marginally exceeding its own target to raise funds [2]. However, the specific amount raised in excess of its target was not specified.
In a recent strategic move, Temasek is also looking to invest in more Indian family-run businesses, following its deal with Haldiram's [5]. This expansion into Indian family-run businesses is expected to further diversify Temasek's portfolio.
In conclusion, LeapFrog Investments' strategic hire and Temasek's continued expansion into Indian family-run businesses and growth markets are clear indications of the firms' commitment to investing in the healthcare sector and emerging markets. As both companies continue to grow and evolve, their impact on the healthcare landscape across the globe is expected to be significant.
References: 1. LeapFrog Investments 2. Redcliffe Labs 3. Business Standard 4. Temasek 5. The Economic Times
The strategic hire at LeapFrog Investments, with a background in finance and investment, will likely contribute to the firm's efforts to further expand its footprint in the healthcare sector within growth markets. This move aligns with LeapFrog’s broader mission of investing in tech-enabled businesses delivering essential healthcare services across emerging markets. Additionally, Temasek, a key stakeholder in LeapFrog Investments, continues to show commitment to the healthcare sector and emerging markets by looking to invest in more Indian family-run businesses, as indicated by their deal with Haldiram's.
